Altasciences Featured Content

  1. CLINDMO: Where Clinical Innovation Meets Manufacturing Excellence 10/7/2025

    Discover how our ClinDMO model transforms early drug development with on-demand manufacturing, adaptive formulation, and real-time decision-making to accelerate timelines and optimize API use.

  2. Clinical Trials Without Boundaries: Multi-Site Solutions At Altasciences 8/21/2025

    Altasciences offers flexible clinical trial models — from single-site to multi-center — to accelerate recruitment, expand patient access, and ensure high-quality trials aligned with your protocol.

  3. Central Nervous System (CNS) Drug Development, Simplified 7/9/2025

    Discover a global CNS leader with 200+ studies completed to date and end-to-end drug development expertise—bridging translational gaps and accelerating your path from discovery to delivery.

  4. Challenges With Hallucinogens, Psychedelics, And Entactogens 5/9/2025

    This eBook examines the complex regulatory landscape and the preclinical, clinical, and manufacturing challenges involved in developing Schedule 1 therapeutics.

  5. Safety Assessment For Ophthalmic Products 2/20/2025

    Dive into the world of ophthalmic drug development, where careful considerations in the preclinical phase must be taken to facilitate advancement into first-in-human clinical trials.

  6. Comprehensive Services For Ophthalmic Drug Development 2/20/2025

    To maximize bioavailability while preserving vision and maintaining the structural integrity of the eye, formulation and delivery strategies must be meticulously designed.

  7. The Complexities Of Early Phase Ophthalmic Drug Development 2/20/2025

    Navigating the landscape of ophthalmic drug development can be challenging. Check out this scientific journal that outlines potential challenges, and how to overcome them.

  8. Factors Affecting Systemic Drug Exposure 1/22/2025

    The increasing number of drugs on the market leads to a greater potential for DDIs. Determining the extent of the interaction and associated risks is an important safety consideration.

  9. The Complexities Of GLP-1 Receptor Agonist Drug Development 11/20/2024

    Review the requirements for successful GLP-1 drug development, including preclinical research approaches, clinical study designs, bioanalytical techniques, and manufacturing challenges.

  10. Toxicokinetics, Pharmacokinetics, And Pharmacodynamics 11/20/2024

    Discover why gathering and analyzing pharmacokinetic (PK) and pharmacodynamic (PD) data is key — from preclinical studies right to clinical trial conduct.